“Attenuating Renal Interstitial Fibrosis by Shenqi Pill via Reducing Inflammation Response Regulated by NF-κB Pathway In Vitro and In Vivo”. Iranian Journal of Kidney Diseases, vol. 18, no. 2, June 2024, pp. 87-98, https://doi.org/10.52547/ggc27334.